WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for AXSM

Based on 11 analysts offering 12 month price targets for Axsome Therapeutics Inc.
Min Forecast
$106.00+27.97%
Avg Forecast
$125.82+51.9%
Max Forecast
$190.00+129.39%

Should I buy or sell AXSM stock?

Based on 11 analysts offering ratings for Axsome Therapeutics Inc.
Strong Buy
Strong Buy
8 analysts 72.73%
Buy
3 analysts 27.27%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AXSM stock forecasts and price targets.

AXSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-12
lockedlocked$00.00+00.00%2024-06-06
lockedlocked$00.00+00.00%2024-06-05
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-05-07
Morgan Stanley
Bottom 4%
4
Strong BuyUpgrades$115.00+38.84%2024-04-29
Cantor Fitzgerald
Top 4%
97
Strong BuyReiterates$107.00+29.18%2024-04-10
Truist Securities
Top 6%
95
Strong BuyMaintains$150.00+81.09%2024-03-26
Guggenheim
Top 32%
69
Strong BuyMaintains$125.00+50.91%2024-02-21Find out why
UBS
Top 28%
73
Strong BuyInitiates Coverage On$111.00+34.01%2024-02-06

1 of 2

Forecast return on equity

Is AXSM forecast to generate an efficient return?
Company
253.25%
Industry
73.55%
Market
80.58%
AXSM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AXSM forecast to generate an efficient return on assets?
Company
66.84%
Industry
31.45%
AXSM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AXSM earnings per share forecast

What is AXSM's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$4.68
Avg 2 year Forecast
-$0.19
Avg 3 year Forecast
$5.16

AXSM revenue forecast

What is AXSM's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$362.9M+44.57%
Avg 2 year Forecast
$639.0M+154.54%
Avg 3 year Forecast
$1.0B+305.06%
AXSM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AXSM revenue growth forecast

How is AXSM forecast to perform vs Biotechnology companies and vs the US market?
Company
58.02%
Industry
37.21%
Market
10.62%
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AXSM$82.83$125.82+51.90%Strong Buy
RARE$45.14$84.91+88.10%Strong Buy
CRNX$53.67$68.60+27.82%Strong Buy
DYN$41.54$40.88-1.60%Strong Buy
RNA$44.80$48.20+7.59%Strong Buy

Axsome Therapeutics Stock Forecast FAQ

Is Axsome Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: AXSM) stock is to Strong Buy AXSM stock.

Out of 11 analysts, 8 (72.73%) are recommending AXSM as a Strong Buy, 3 (27.27%) are recommending AXSM as a Buy, 0 (0%) are recommending AXSM as a Hold, 0 (0%) are recommending AXSM as a Sell, and 0 (0%) are recommending AXSM as a Strong Sell.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What is AXSM's earnings growth forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.03%.

Axsome Therapeutics's earnings in 2024 is -$296,377,000.On average, 6 Wall Street analysts forecast AXSM's earnings for 2024 to be -$222,199,727, with the lowest AXSM earnings forecast at -$245,078,467, and the highest AXSM earnings forecast at -$177,634,393. On average, 10 Wall Street analysts forecast AXSM's earnings for 2025 to be -$9,119,199, with the lowest AXSM earnings forecast at -$185,708,684, and the highest AXSM earnings forecast at $167,660,269.

In 2026, AXSM is forecast to generate $245,078,467 in earnings, with the lowest earnings forecast at $94,991,654 and the highest earnings forecast at $571,849,757.

What is AXSM's revenue growth forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's forecast annual revenue growth rate of 58.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Axsome Therapeutics's revenue in 2024 is $251,023,000.On average, 7 Wall Street analysts forecast AXSM's revenue for 2024 to be $17,236,853,064, with the lowest AXSM revenue forecast at $16,547,546,127, and the highest AXSM revenue forecast at $18,271,644,647. On average, 7 Wall Street analysts forecast AXSM's revenue for 2025 to be $30,347,886,124, with the lowest AXSM revenue forecast at $22,214,273,246, and the highest AXSM revenue forecast at $35,058,759,725.

In 2026, AXSM is forecast to generate $48,293,329,431 in revenue, with the lowest revenue forecast at $42,603,756,819 and the highest revenue forecast at $57,237,031,134.

What is AXSM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AXSM) forecast ROA is 66.84%, which is higher than the forecast US Biotechnology industry average of 31.45%.

What is AXSM's Price Target?

According to 11 Wall Street analysts that have issued a 1 year AXSM price target, the average AXSM price target is $125.82, with the highest AXSM stock price forecast at $190.00 and the lowest AXSM stock price forecast at $106.00.

On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $125.82 by Jun 12, 2025. The average Axsome Therapeutics stock price prediction forecasts a potential upside of 51.9% from the current AXSM share price of $82.83.

What is AXSM's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: AXSM) Axsome Therapeutics's current Earnings Per Share (EPS) is -$6.43. On average, analysts forecast that AXSM's EPS will be -$4.68 for 2024, with the lowest EPS forecast at -$5.16, and the highest EPS forecast at -$3.74. On average, analysts forecast that AXSM's EPS will be -$0.19 for 2025, with the lowest EPS forecast at -$3.91, and the highest EPS forecast at $3.53. In 2026, AXSM's EPS is forecast to hit $5.16 (min: $2.00, max: $12.04).

What is AXSM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AXSM) forecast ROE is 253.25%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.